Exelixis, Inc.
EXELNASDAQHealthcare● Active
$52.70
+$0.21(+0.40%)
Market Cap$13.2B
P/E Ratio—
52W High$52.98
52W Low$33.76
Exelixis, Inc. (EXEL) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EXEL · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2026-01 | 2025-01 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.32B | $2.17B | $1.83B | $1.61B | $1.43B |
| Cost of Revenue | $0.08B | $0.08B | $0.07B | $0.06B | $0.05B |
| Gross Profit | $2.24B | $2.09B | $1.76B | $1.55B | $1.38B |
| Gross Margin %(computed) | 96.39% | 96.49% | 96.04% | 96.41% | 96.32% |
| Operating Expenses | |||||
| R&D Expenses | $0.83B | $0.91B | $1.04B | $0.89B | $0.69B |
| G&A Expenses | $0.47B | $0.49B | $0.54B | $0.42B | $0.37B |
| Total Operating Expenses | $1.36B | $1.49B | $1.59B | $1.35B | $1.10B |
| Operating Income | $0.87B | $0.60B | $0.17B | $0.20B | $0.29B |
| Operating Margin %(computed) | 37.59% | 27.88% | 9.34% | 12.51% | 19.98% |
| Interest Income | $0.07B | $0.08B | $0.09B | $0.03B | $0.01B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.94B | $0.68B | $0.26B | $0.23B | $0.29B |
| Income Tax Expense | $0.16B | $0.16B | $0.05B | $0.05B | $0.06B |
| Net Income | $0.78B | $0.52B | $0.21B | $0.18B | $0.23B |
| Net Margin %(computed) | 33.73% | 24.04% | 11.35% | 11.31% | 16.10% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $2.88 | $1.80 | $0.65 | $0.57 | $0.73 |
| Wtd Avg Shares | 0.27B | 0.29B | 0.32B | 0.32B | 0.31B |
| EBITDA | $0.92B | $0.72B | $0.20B | $0.22B | $0.30B |
| EBITDA Margin %(computed) | 39.73% | 33.14% | 10.74% | 13.80% | 20.93% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Exelixis, Inc. data
About Exelixis, Inc. (EXEL) Income Statement
Exelixis, Inc. (EXEL) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2026, EXEL reported revenue of $2.32B, gross profit of $2.24B (gross margin 96.39%), and net income of $0.78B — a net profit margin of 33.73%.
Frequently asked questions
EXEL · 4 questionsExelixis, Inc. (EXEL) reported revenue of $2.32B for 2026, up 7.0% year-over-year.
EXEL revenueEXEL salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08